Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Scopus

Scopus profile and journal metrics

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022
First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
Original full research article

Prevalence of Glycemic Control and Factors Associated With Increasing Levels of Hba1c Among A Sample of Palestinian Patients With Type 2 Diabetes Mellitus

Published
2017-05-25
Pages
82 - 92
Full text

Keywords

  • Palestine
  • Diabetes Mellitus
  • Glycemic Control
  • Multivariate Analysis

Abstract

Diabetes mellitus (DM) is an increasing health challenge. Control of blood glucose level, as measured by level of glycated hemoglobin (HbA1c), is used as an indicator of glycemic control and potential risk of diabetic complications. This study aimed to investigate the extent of glycemic control among type 2 diabetic patients and to determine factors associated with increasing levels of HbA1c.A total of 380 patients were interviewed using a questionnaire prepared for this cross – sectional study. The patients were recruited from a diabetic clinic in Nablus, Palestine. Clinical laboratory data and HbA1c values were obtained from medical files of the patients while demographic information were obtained through face-to-face interview. The participants had a mean ± standard deviation (SD) age of 60 ± 10 years. A total of 71 (18.7%) participants were less than 50 years of age. The participants had a mean body mass index (BMI) of 32.7± 6 Kg/m2 with more than two thirds were considered obese with a BMI of ≥ 30 Kg/m2. The studied patients have a mean ± SD of HbA1c of 8.3± 1.8. The median of HbA1c was 8.05 with interquartile range of (First quartile (Q1) = 6.93; Third quartile (Q3) = 9.5). The majority of studied patients (278; 73.2%) had HbA1c value above 7%. The mean ± SD healthcare index (HCI) of the studied patients was 4.29 ± 1.49. Univariate analysis showed that age (p<0.01), total cholesterol (p<0.01), low density lipoprotein (LDL) (p<0.01), high density lipoprotein (HDL) (p=0.028), HIC (p<0.01), and type of therapeutic regimen (p<0.01) were significantly correlated with HbA1c. Multivariate analysis indicated that younger age, lower HDL values, combination therapy with insulin were significantly associated with increasing levels of HbA1c.High proportion of patients recruited for this study had poor glycemic control. Younger age was associated with higher HbA1c values which necessitates urgent and immediate medical intervention at the primary healthcare level

Article history

Received
2017-05-03
Accepted
2017-05-25
بحث أصيل كامل

Prevalence of Glycemic Control and Factors Associated With Increasing Levels of Hba1c Among A Sample of Palestinian Patients With Type 2 Diabetes Mellitus

Published
2017-05-25
الصفحات
82 - 92
البحث كاملا

الكلمات الإفتتاحية

  • Palestine
  • Diabetes Mellitus
  • Glycemic Control
  • Multivariate Analysis

الملخص

Diabetes mellitus (DM) is an increasing health challenge. Control of blood glucose level, as measured by level of glycated hemoglobin (HbA1c), is used as an indicator of glycemic control and potential risk of diabetic complications. This study aimed to investigate the extent of glycemic control among type 2 diabetic patients and to determine factors associated with increasing levels of HbA1c.A total of 380 patients were interviewed using a questionnaire prepared for this cross – sectional study. The patients were recruited from a diabetic clinic in Nablus, Palestine. Clinical laboratory data and HbA1c values were obtained from medical files of the patients while demographic information were obtained through face-to-face interview. The participants had a mean ± standard deviation (SD) age of 60 ± 10 years. A total of 71 (18.7%) participants were less than 50 years of age. The participants had a mean body mass index (BMI) of 32.7± 6 Kg/m2 with more than two thirds were considered obese with a BMI of ≥ 30 Kg/m2. The studied patients have a mean ± SD of HbA1c of 8.3± 1.8. The median of HbA1c was 8.05 with interquartile range of (First quartile (Q1) = 6.93; Third quartile (Q3) = 9.5). The majority of studied patients (278; 73.2%) had HbA1c value above 7%. The mean ± SD healthcare index (HCI) of the studied patients was 4.29 ± 1.49. Univariate analysis showed that age (p<0.01), total cholesterol (p<0.01), low density lipoprotein (LDL) (p<0.01), high density lipoprotein (HDL) (p=0.028), HIC (p<0.01), and type of therapeutic regimen (p<0.01) were significantly correlated with HbA1c. Multivariate analysis indicated that younger age, lower HDL values, combination therapy with insulin were significantly associated with increasing levels of HbA1c.High proportion of patients recruited for this study had poor glycemic control. Younger age was associated with higher HbA1c values which necessitates urgent and immediate medical intervention at the primary healthcare level

Article history

تاريخ التسليم
2017-05-03
تاريخ القبول
2017-05-25